HIGHLIGHTS
- who: Freek Haerkens from the BioCentre, HAN University of Applied Sciences, EM, Nijmegen, the Netherlands have published the paper: A new use for old drugs: identifying compounds with an anti-obesity effect using a high through-put semi-automated Caenorhabditis elegans screening platform, in the Journal: (JOURNAL)
- what: The aim of the pipeline was to identify drugs that are currently on the market that are able to reduce fat and could be repurposed as an antiobesity drug. The authors show that the use of C. elegans in high throughput screens indeed enables compounds to be . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.